openPR Logo
Press release

Global Real World Evidence Solutions Market Hits $2.9 billion by 2027- Leading Key Players are IQVIA Holdings Inc. (US), IBM Corporation (US), OPTUM Inc. (US), Icon Plc (Ireland), Syneos Health Inc. (US), Parexel International Corporation (US), Thermo Fis

02-20-2023 03:46 PM CET | Health & Medicine

Press release from: MarketsandMarkets

Real World Evidence Solutions Market

Real World Evidence Solutions Market

According to the new market research report "Real World Evidence Solutions Market by Component (Services, Disparate Data Sets, (Claims, Clinical, Pharmacy, Patient), Application (Oncology, Cardiovascular, Neurology, Immunology), End User (Pharma, Medtech, Payers, Providers) - Global Forecast to 2027", The global RWE Solutions market is projected to reach USD 2.9 Billion by 2027 from USD 1.5 Billion in 2022, at a CAGR of 15.2% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991&utm_source=OPenpr&utm_medium=paid&utm_campaign=referral

Browse in-depth TOC on "Real World Evidence Solutions Market"
190 - Tables
60 - Figures
265 - Pages

Increasing growth in clinical trials, rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), and the shift from volume- to value-based care are the key factors driving the growth of this market. Additionally, delays in drug development (and the subsequent increase in development costs), rise in R&D spending, and support from regulatory bodies for the use of RWE solutions are some of the other major factors that are driving the market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76173991&utm_source=OPenpr&utm_medium=paid&utm_campaign=referral

In this report, the RWE solutions market is segmented on the basis of component, application, end user, and region. Based on component, the RWE solutions market is divided into two major segments, namely, data sets and services. The services segment accounted for the largest share of the RWE solutions market in 2021. The rise in the need to convert data into actionable evidence, the growth in the need to reduce drug development delays, and the availability of a large volume of healthcare data are the major factors driving the growth of this market segment. The data sets segment is further sub segmented into disparate data sets and integrated data sets. The disparate data sets segment dominated the market, based on the type of data sets, owing to their significant adoption in complementing randomized clinical trial-based studies. The disparate data sets segment is further sub-segmented as clinical settings data, claims data, pharmacy data, patient-powered data, and registry-based data sets. The clinical settings data segment dominated the disparate data type segment, owing to the high demand for EMR data in generating patient-specific evidence.

Based on application, the RWE solutions market is broadly categorized into drug development and approvals, medical device development and approvals, post-market surveillance, market access reimbursement/coverage decision making, and clinical and regulatory decision-making. The drug development and approval segment dominated the market in 2021. This significant contribution of the segment can be attributed to the significant use of RWD and RWE solutions in ensuring the safety of drugs and complementing randomized clinical trials. Based on the drug discovery and approval (therapeutic applications), the RWE solutions market is further sub-categorized into oncology, neurology, immunology, cardiovascular disease, and other therapeutic areas. The oncology segment accounted for the largest share in 2021, owing to the high number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

Based on end user, the RWE solutions market is broadly segmented into pharmaceutical & medical device companies, healthcare providers, healthcare payers, and other end users (CROs, academic institutions, patient advocacy groups, and health technology assessment agencies). The pharmaceutical & medical device companies segment accounted for the largest share in 2021. The large share and high growth of this end-user segment can be attributed to the an increasing use of RWE solutions in meeting regulatory compliances and rise in clinical trials.

Geographical Growth Scenario:

The global RWE solutions market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global RWE solutions market in 2021. Factors, such as shift from volume to value-based care, favorable regulatory environment, the rising number of payers using RWD, and the increasing number of pharmaceutical companies adopting RWE for drug approval processes are driving the growth of the RWE solutions market in North America. Asia Pacific region is expected to witness highest growth rate during the forecast period. Factors such as rising burden of chronic diseases, increasing geriatric population in countries such as Japan and China, increasing government initiatives for the adoption of RWE studies are some of the factors that are driving the growth of the RWE solutions market in Asia Pacific region.

Key Players:

The key players operating in the RWE solutions market include IQVIA Holdings Inc. (US), IBM Corporation (US), OPTUM Inc. (US), Icon Plc (Ireland), Syneos Health Inc. (US), Parexel International Corporation (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=76173991&utm_source=OPenpr&utm_medium=paid&utm_campaign=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Real World Evidence Solutions Market Hits $2.9 billion by 2027- Leading Key Players are IQVIA Holdings Inc. (US), IBM Corporation (US), OPTUM Inc. (US), Icon Plc (Ireland), Syneos Health Inc. (US), Parexel International Corporation (US), Thermo Fis here

News-ID: 2938304 • Views:

More Releases from MarketsandMarkets

Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your Revenue
Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your R …
The global laser interferometer market is expected to be valued at 315 million in 2024 and is projected to reach USD 447 million by 2029, at a CAGR of 7.2% from 2024 to 2029. Emerging applications in industries push the market's growth due to the growing demand for precision in the manufacturing sector. However, challenges such as higher initial investments and maintenance costs cause problems. Despite these, opportunities arise for
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to Surpass USD 36.7 billion
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to …
The battery testing, inspection, and certification market is projected to reach USD 36.7 billion by 2029 from USD 14.9 billion in 2024 at a CAGR of 19.6% during the forecast period. Increasing adoption of EVs and energy storage systems, rising enforcement of stringent standards to ensure battery safety, thriving portable electronics industry, and rapid advances in battery technology are the major factors contributing to the market growth. Download PDF Brochure @
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMarkets
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMar …
The global RTLS market for healthcare is projected to grow from USD 2.3 billion in 2024 to USD 5.7 billion by 2029, at a compound annual growth rate of 19.6% from 2024 to 2029. As it attracts more and more players who enter this market with innovative RTLS features for customers, the market for RTLS technology is rapidly increasing. Top companies in this market focus on healthcare, retail, and manufacturing
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2030 | Leading key players are ABB, Schneider Electric, Eaton, Vertiv
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2 …
According to a research report "Offsite Data Center Power Infrastructure Market by Component (Solutions and Services), Vertical (BFSI, Media & Entertainment, Government & Defence, Healthcare, Manufacturing, IT & Telecom, Retail) and Region - Global Forecast to 2030" published by MarketsandMarkets, the market size for global offsite data center power infrastructure market is projected to reach approximately USD 35.4 billion by the year 2030, as compared to the estimated value of

All 5 Releases


More Releases for RWE

Wood-Pellets Market Expected to Reach Nearly USD 9.0 Billion by 2031 | RWE Innog …
QYResearch A newly published report titled "Global Wood-Pellets Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Wood-Pellets market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and
U.S. Real-World Evidence (RWE) Solutions Market - Forecast to 2029
Meticulous Research®- leading U.S. market research company published a research report titled "U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029." Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5243 According to this latest publication from Meticulous Research®, the U.S. real-world evidence (RWE) solutions market is expected to grow at a CAGR of 13.1%
Real-world Evidence (RWE) Analytics Market Worth $2.93 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'RWE Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], End User (Pharma, Payer, Provider) - Global Forecast to 2029'. Access Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5306 According to this latest publication from Meticulous Research®, the global real-world evidence (RWE) analytics market is expected to grow
Sales of Real World Evidence/RWE Solutions Industry by 2031 | GIS
Global Real World Evidence/RWE Solutions Market report from Global Insight Services is the single authoritative source of intelligence on Real World Evidence/RWE Solutions Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data
Real-World Evidence (RWE) Oncology Market Worth $1.65 Billion by 2029
According to a new market research report titled, 'RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), and End User (Pharma, Payer) - Global Forecast to 2029,' published by Meticulous Research®, the real-world evidence oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029. Download Free Sample Report
Nuclear Power Plant Market Next Big Thing | Kepco, Magnox, RWE, Entergy
Nuclear power plant (NPP) uses nuclear fission reaction to heat water to produce steam which runs the turbines to generate electricity. The fission process occurs inside the reactor where uranium fuel is stored in its core. Considering the high fuel to output ratio produced by these power plants, countries are heavily investing in development of nuclear power plant. United States accounts for 20% of their total electricity production through nuclear